Ferrous fumarate

ApprovedSmall molecule

GSK

Ferrous fumarate is one of 95 small molecule programs targeting Iron deficiency anemia. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Iron Deficiency AnemiaActive, not recruiting

AnemiaActive, not recruiting

Inflammatory Bowel DiseaseActive, not recruiting

Iron Deficiency AnemiaPreclinical

Active, not recruiting

AnemiaApproved

Active, not recruiting

Inflammatory Bowel DiseaseApproved

Active, not recruiting

Competition

Competitive Landscape

272 competitors in Anemia

#DrugCompanyPhaseTrials

Methoxy Polyethylene Glycol-Ep

Roche

Phase 3

36 2

Omontys

Takeda

Phase 3

9 3

Alkeran

AApotex Inc.

Phase 3

1 4

Ferrous fumarate

GSK

Approved

1 5

Epogen

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Preclinical

52 6

Aranesp

Amgen

Preclinical

38 7

Iron Sucrose Injection USP

WWatson Pharmaceuticals

Phase 3

2 8

JTZ-951

AAkros Pharma Inc.

Phase 3

1 9

Farxiga

AstraZeneca

Preclinical

1 10

Cytosar

Teva

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q1 2027

Phase 3Not yet recruiting

Iron Deficiency Anemia

NCT07381426

Q4 2027

N/ARecruiting

Iron Deficiency Anemia

NCT07014371

Clinical

Trials by Indication[1]

Iron deficiency anemia5 trials

Iron Dextran Versus Oral Iron for Treating Iron Deficiency Anemia in Pregnant Women

Completed·—·Phase 3·NCT03212781·66 enrolled

Thrice-weekly Versus Thrice-daily Oral Ferrous Fumarate Treatment in Adult Patients With Iron Deficiency Anemia

Completed·PPrince of Songkla University·Phase 3·NCT04130828·66 enrolled

Efficacy of Iron Bisglycinate in Treatment of Iron Deficiency Anemia in Pregnant Women

Completed·HHatem AbuHashim·Phase 3·NCT03378791·120 enrolled

Show 2 more trials

Ferric Citrate in Iron Deficiency Anemia During Pregnancy

Not yet recruiting·—·Phase 3·NCT07381426·680 enrolled

Alternative vs. Once-Daily Oral Iron Supplementation in Iron Deficiency Anemia (IDA)

Recruiting·PPhramongkutklao College of Medicine and Hospital·N/A·NCT07014371·114 enrolled

Efficacy and Safety2 trials

Study of the Contraceptive Efficacy and Safety of a NOMAC-E2 Combined Oral Contraceptive (COC)(P06448)

Terminated·OOrganon and Co·Phase 3·NCT01656434·3,173 enrolled

EffiCacy and sAfEty of Low doSe orAl iRon for Anaemia in IBD

Unknown status·LLiverpool University Hospitals NHS Foundation Trust·Phase 3·NCT06321887·30 enrolled

Inflammatory Bowel Disease1 trial

Predicting Response to Iron Supplementation in Patients With Active Inflammatory Bowel Disease

Unknown status·LLeiden University Medical Center·Phase 4·NCT05456932·90 enrolled

Gastric1 trial

Optimizing Iron Suppletion After Roux-en-Y Gastric Bypass

Completed·RRijnstate Hospital·Phase 4·NCT02271997·120 enrolled

Anemia1 trial

The Use of Iron Therapy for Patients With Anemia After Caesarean Section

Terminated·MMaastricht University Medical Center·Phase 4·NCT01975272·27 enrolled

8 more indications

Pregnant Women1 trial

The Efficacy of Intermittent Versus Daily Oral Iron Supplementation in Anaemic Pregnant Women.

Unknown status·MMartini Hospital Groningen·Phase 4·NCT05278793·58 enrolled

Treatment1 trial

Trial Comparing Ferric(III)Carboxymaltose Infusion With Oral Iron Suppletion as Treatment of Anaemia

Unknown status·—·Phase 4·NCT02243735·198 enrolled

Anti-inflammatory Therapy1 trial

Oral Versus Intravenous Iron in IBD Patients With Anti-inflammatory Therapy.

Unknown status·LLeiden University Medical Center·N/A·NCT05581420·152 enrolled

Absorption1 trial

Iron Absorption Trial

Completed·RRijnstate Hospital·Phase 4·NCT02228902·24 enrolled

Complication1 trial

Preoperative Intravenous Iron Infusion to Reduce Post-surgical Complications: a Pilot Randomised Control Trial

Unknown status·SSingapore General Hospital·Phase 4·NCT03295851·60 enrolled

Cardiovascular Surgery1 trial

Oral and Intravenous Iron in Patients Postoperative Cardiovascular Surgery Under Extracorporeal Circulation

Completed·FFundación Canaria Rafael Clavijo para la Investigación Biomédica·Phase 4·NCT01078818·159 enrolled

Adult Subject1 trial

A Study to Evaluate the Effects of Calcium Carbonate and Ferrous Fumarate on Pharmacokinetics of Dolutegravir in Healthy Adult Subjects

Completed· GSK logo

GSK·Phase 1·NCT01762995·24 enrolled

Unspecified1 trial

Ferrous Fumarate and Ferric Pyrophosphate as Food Fortificants in Developing Countries

Completed·IInternational Centre for Diarrhoeal Disease Research, Bangladesh·Phase 1·NCT00867867·235 enrolled

Sources

References

[1]
ClinicalTrials.gov — 18 trial records for Ferrous fumarate. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Ferrous fumarate compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Ferrous fumarate. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — GSK company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: GSK

Ferrous fumarate

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q1 2027

Q4 2027

Trials by Indication[1]

Iron deficiency anemia5 trials

Efficacy and Safety2 trials

Inflammatory Bowel Disease1 trial

Gastric1 trial

Anemia1 trial

Pregnant Women1 trial

Treatment1 trial

Anti-inflammatory Therapy1 trial

Absorption1 trial

Complication1 trial

Cardiovascular Surgery1 trial

Adult Subject1 trial

Unspecified1 trial

References

Drug Info

Quick Facts

Related News